Eye Cream

Measured on subjects having dry to very dry skin on the forearms, verified using Corneometer® and Tewameter®.

The skin of trial participant showing wrinkles on day 0 and after 28 days of using product twice a day, captured by VISIA® Skin Analysis System.

BIOMETROLOGICAL EVALUATION OF THE LONG-LASTING MOISTURIZING AND TRANSEPIDERMAL WATER LOSS EFFECT

Measured on subjects having dry to very dry skin on the forearms, verified using Corneometer® and Tewameter®.

MOISTURIZING

presented a significant long-lasting moisturizing effect until t8h

+34%

increased hydration after 2 hours

100%

of subjects presenting an improvement

+24%

increased hydration after 4 hours

+16%

increased hydration after 6 hours

+10%

increased hydration after 8 hours

CUTANEOUS BARRIER REINFORCEMENT

-16%

of transepidermal water loss after 2 hours

+82%

of subjects with a cutaneous barrier reinforcement

-13%

of transepidermal water loss after 4 hours

+64%

of subjects with a cutaneous barrier reinforcement

Moisturizing effect

Product moisturizing effect was measured using Corneometer® after two, four, six, and eight hours after a single standardized application.

AVL Eye Cream provides a significant moisturizing effect until 8 hours after use.

Cutaneous Barrier reinforcement

Transepidermal Water Loss was measured using Corneometer® and Tewameter® after two, four, six and eight hours after a single standardized application.

AVL Eye Cream presents a cutaneous barrier reinforcement until 4 hours after use and a cutaneous barrier maintenance until 8 hours after use.

EVALUATION OF THE OCULAR POTENTIAL IRRITANCY

The cytotoxicity is evaluated by measuring the mean diameter (MD) of cell lysis in agarose gel on 4 dishes and calculating the mean.

This value is presented in centimeters, to one decimal place.

AVL reference product

MD [cm]

Classification

Conclusion

Eye Cream

0.0

Low cytotoxicity

The test item does not have irritant properties

EVALUATION OF THE SKIN COMPATIBILITY

Measured after single application on adult subjects under dermatological control.

100 subjects – 50 sensitive skin and 50 normal skin, where M.C.I.I. = Mean Cumulative Irritation Index

AVL reference product

Skin Type

Concentration / Type

Patch duration

M.C.I. I.

Conclusion

Eye Cream

Normal

20 μl Pure / Occlusive

48 hours

0.04

Non irritating

Eye Cream

Sensitive

20 μl Pure / Occlusive

48 hours

0.05

Non irritating